Dashboard
Poor long term growth as Operating profit has grown by an annual rate -6.47% of over the last 5 years
With a fall in Net Sales of -16.36%, the company declared Very Negative results in Sep 25
With ROCE of 1.8, it has a Very Expensive valuation with a 1.7 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.25% of the company
Underperformed the market in the last 1 year
Stock DNA
Commodity Chemicals
INR 592 Cr (Micro Cap)
NA (Loss Making)
39
0.30%
0.29
0.82%
1.53
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alka. Sees Revision in Market Assessment Amid Challenging Financial Trends
Chemfab Alka., a microcap player in the Commodity Chemicals sector, has experienced a revision in its market assessment reflecting ongoing challenges in its financial and technical performance. The recent changes in evaluation metrics highlight concerns across multiple parameters including quality, valuation, financial trends, and technical outlook, underscoring the company’s current position within a competitive and volatile market environment.
Read More
Chemfab Alkalis Falls to 52-Week Low of Rs.481.1 Amidst Continued Downtrend
Chemfab Alkalis, a key player in the Commodity Chemicals sector, has touched a new 52-week low of Rs.481.1 today, marking a significant milestone in its ongoing price decline. The stock has experienced heightened volatility and underperformance relative to its sector and broader market indices over recent sessions.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-Jan-2026 | Source : BSESubmission of newspaper clippings on publication of unaudited financial results for the quarter and nine months ended 31st December 2025
Submission Of Investor Presentation
29-Jan-2026 | Source : BSESubmission of investor presentation for the quarter ended 31st December 2025
Results-Delay in Financial Results
28-Jan-2026 | Source : BSEDear Sir Due to technical glitch the unaudited financial results in the results module couldnt be uploaded within prescribed time slot. The same was filed as part of outcome in prescribed time limit. Attached the file for your records.
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.08%)
Dr Rao Holdings Pte Ltd (47.04%)
V. M. Srinivasan (1.8%)
21.56%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -11.00% vs -16.36% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -121.39% vs -178.82% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 2.16% vs -1.23% in Mar 2024
YoY Growth in year ended Mar 2025 is -126.37% vs -59.24% in Mar 2024
